Insulin resistance and cardiovascular drugs.
Under certain circumstances the effect of insulin to promote glucose uptake in peripheral tissues is reduced because of a resistance to insulin action. This insulin resistance and the resulting hyperinsulinaemia are now recognised as common background factors that may be responsible for hypertension, hyperlipidaemia, decreased thrombolysis and also impaired glucose tolerance and diabetes. Hyperinsulinaemia has also been identified as an independent risk factor for coronary heart disease and promotes smooth muscle cell growth and plaque formation. A series of studies have now demonstrated that treatment with selective beta-blockers as well as thiazide diuretics impair insulin sensitivity by 15-30% and causes a compensatory increase in insulin concentrations. Furthermore, lipoprotein concentrations are affected in an unfavourable way. This is in contrast to the drugs belonging to ACE-inhibitors, calcium-channel blockers and alpha 1-blocker classes that are either neutral or may have the opposite effects in these respects.
Lithell
H
H
Department of Geriatrics, Uppsala University, Sweden.
D000959:Antihypertensive Agents / Q000009:adverse effects; D002317:Cardiovascular Agents / Q000009:adverse effects*; D003327:Coronary Disease / Q000209:etiology / Q000517:prevention & control; D006801:Humans; D006946:Hyperinsulinism / Q000139:chemically induced / Q000150:complications; D000960:Hypolipidemic Agents / Q000009:adverse effects; D007333:Insulin Resistance
D000959:Antihypertensive Agents; D002317:Cardiovascular Agents; D000960:Hypolipidemic Agents